AU2002301845A1 - Modified release tamsulosin tablets - Google Patents

Modified release tamsulosin tablets

Info

Publication number: AU2002301845A1
Authority: AU; Australia
Prior art keywords: modified release; release tamsulosin; tamsulosin tablets; tablets; modified
Prior art date: 2001-11-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002301845A

Other versions

AU2002301845B2 (en

Inventor

Juan Cucala Escoi

Jacobus Maria Lemmens

Arturo Siles Ortega

Johannes J. Platteeuw

Frans Van Dalen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Synthon BV

Original Assignee

Synthon BV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-07

Filing date

2002-11-06

Publication date

2003-06-12

2002-11-06 Application filed by Synthon BV filed Critical Synthon BV

2003-06-12 Publication of AU2002301845A1 publication Critical patent/AU2002301845A1/en

2008-06-05 Application granted granted Critical

2008-06-05 Publication of AU2002301845B2 publication Critical patent/AU2002301845B2/en

2022-11-06 Anticipated expiration legal-status Critical

Status Expired legal-status Critical Current

Links

DRHKJLXJIQTDTD-OAHLLOKOSA-N Tamsulosine Chemical compound CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 DRHKJLXJIQTDTD-OAHLLOKOSA-N 0.000 title 1
229960002613 tamsulosin Drugs 0.000 title 1

AU2002301845A 2001-11-07 2002-11-06 Modified release tamsulosin tablets Expired AU2002301845B2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US33105501P	2001-11-07	2001-11-07
US60/331,055		2001-11-07

Publications (2)

Publication Number	Publication Date
AU2002301845A1 true AU2002301845A1 (en)	2003-06-12
AU2002301845B2 AU2002301845B2 (en)	2008-06-05

Family

ID=23292437

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002301845A Expired AU2002301845B2 (en)	2001-11-07	2002-11-06	Modified release tamsulosin tablets

Country Status (21)

Country	Link
US (2)	US20030147950A1 (en)
EP (3)	EP1443917B1 (en)
JP (3)	JP2005512997A (en)
CN (3)	CN1298317C (en)
AT (3)	ATE321544T1 (en)
AU (1)	AU2002301845B2 (en)
CA (2)	CA2465110A1 (en)
CZ (3)	CZ16813U1 (en)
DE (4)	DE20220415U1 (en)
DK (3)	DK1443917T3 (en)
ES (2)	ES2256544T3 (en)
HU (2)	HUP0401978A3 (en)
IL (4)	IL161491A0 (en)
NL (2)	NL1021822C2 (en)
NO (2)	NO340960B1 (en)
NZ (2)	NZ532589A (en)
PT (2)	PT1443917E (en)
RU (2)	RU2311903C2 (en)
SI (2)	SI1443917T1 (en)
WO (2)	WO2003039530A1 (en)
ZA (2)	ZA200403281B (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE20220415U1 (en) *	2001-11-07	2003-10-09	Synthon Bv	Tamsulosin tablets
US7018658B2 (en) *	2002-11-14	2006-03-28	Synthon Bv	Pharmaceutical pellets comprising tamsulosin
IN192381B (en) *	2002-12-20	2004-04-10	Ranbaxy Lab
US20040253309A1 (en) *	2003-01-27	2004-12-16	Yamanouchi Pharmaceutical Co., Ltd.	Enteric sustained-release fine particles of tamsulosin and its salt and manufacturing method thereof
WO2005004851A1 (en) *	2003-07-01	2005-01-20	Krka, Tovarna Zdravil, D.D. Novo Mesto	Tamsulosin core with a coating of polyvinylpyrrolidone and polyvinylacetate
EP1673073A4 (en) *	2003-09-29	2012-03-21	Cj Cheiljedang Corp	Sustained-release formulations
KR100762846B1 (en) *	2003-09-29	2007-10-04	씨제이 주식회사	Sustained-release formulations
JP2005104914A (en) *	2003-09-30	2005-04-21	Kyowa Yakuhin Kogyo Kk	Basic agent-containing pharmaceutical preparation
JP2005162737A (en) *	2003-11-10	2005-06-23	Astellas Pharma Inc	Sustained release medicinal composition
US8197846B2 (en) *	2003-11-10	2012-06-12	Astellas Pharma Inc.	Sustained release pharmaceutical composition
US8128958B2 (en) *	2003-11-10	2012-03-06	Astellas Pharma Inc.	Sustained release pharmaceutical composition
JP2005162736A (en) *	2003-11-10	2005-06-23	Astellas Pharma Inc	Sustained release medicinal composition
AU2003286415A1 (en) *	2003-12-03	2005-06-24	Natco Pharma Limited	An improved pharmaceutical formulation containing tamsulosin salt and a process for its preparation
SI21702A (en) *	2004-01-29	2005-08-31	Lek Farmacevtska Druzba Dd	Preparation of amorphous form of tamsulosin
JP4603803B2 (en) *	2004-01-30	2010-12-22	大洋薬品工業株式会社	Controlled release pharmaceutical composition and formulation using the same
PL204079B1 (en) *	2004-08-12	2009-12-31	Inst Farmaceutyczny	Oral solid tamsulozine hydrochloride preparation with prolonged release and method for its manufacture
WO2006055659A2 (en) *	2004-11-15	2006-05-26	Smithkline Beecham Corporation	Fixed dose combination op dutasteride and tamsulosin
JP2008525313A (en)	2004-12-27	2008-07-17	エーザイ・アール・アンド・ディー・マネジメント株式会社	Anti-dementia drug stabilization method
US20060246003A1 (en) *	2004-12-27	2006-11-02	Eisai Co. Ltd.	Composition containing anti-dementia drug
US20060160852A1 (en) *	2004-12-27	2006-07-20	Eisai Co. Ltd.	Composition containing anti-dementia drug
US20070129402A1 (en) *	2004-12-27	2007-06-07	Eisai Research Institute	Sustained release formulations
US20060159753A1 (en) *	2004-12-27	2006-07-20	Eisai Co. Ltd.	Matrix type sustained-release preparation containing basic drug or salt thereof
US20090208579A1 (en) *	2004-12-27	2009-08-20	Eisai R & D Management Co., Ltd.	Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
KR100678421B1 (en) *	2005-02-11	2007-02-02	주식회사 씨티씨바이오	Controlled-release formulation containing tamsulosin hydrochloride
NZ562120A (en) *	2005-04-28	2010-07-30	Eisai R&D Man Co Ltd	Composition comprising donepezil and memantine as antidementia agents
CN1895241B (en) *	2005-07-12	2010-05-12	可隆制药株式会社	Composition of long-acting oral pills of Yansuan Tanshuluoxin and its production method
WO2007017253A1 (en) *	2005-08-10	2007-02-15	Add Advanced Drug Delivery Technologies Ltd.	Oral preparation with controlled release of a benzenesulphonamide
KR20070021806A (en) *	2005-08-19	2007-02-23	(주)아모레퍼시픽	Sustained-release pellet formulation of ?1-receptor antagonist and process for the preparation thereof
KR20070044911A (en) *	2005-10-26	2007-05-02	주식회사 씨티씨바이오	Controlled-release formulation containing tamsulosin hydrochloride
EP2026766A1 (en) *	2006-05-17	2009-02-25	Synthon B.V.	Tablet composition with a prolonged release of tamsulosin
US20090004284A1 (en) *	2007-06-26	2009-01-01	Watson Pharmaceuticals, Inc.	Controlled release tamsulosin hydrochloride formulation
EP2042169A1 (en) *	2007-09-26	2009-04-01	LEK Pharmaceuticals D.D.	Controlled release tamsulosin hydrochloride tablets and a process of making them
TWI478712B (en)	2008-09-30	2015-04-01	Astellas Pharma Inc	Pharmaceutical composition for modified release
US8465770B2 (en) *	2008-12-24	2013-06-18	Synthon Bv	Low dose controlled release tablet
US20120070465A1 (en)	2010-03-29	2012-03-22	Astellas Pharma Inc.	Pharmaceutical composition for modified release
JP5787881B2 (en)	2010-04-30	2015-09-30	武田薬品工業株式会社	Enteric tablets
TWI566787B (en) *	2011-05-25	2017-01-21	Taiho Pharmaceutical Co Ltd	Contains tegafur, gemcopyrimidine, otiorasilide potassium tablets (b)
CN102579392A (en) *	2012-03-30	2012-07-18	重庆科瑞制药(集团)有限公司	Slow-release preparation containing tamsulosin hydrochloride and preparation method thereof
WO2017186598A1 (en)	2016-04-25	2017-11-02	Synthon B.V.	Modified release tablet composition comprising mirabegron
EP3292864A1 (en)	2017-10-12	2018-03-14	Synthon B.V.	Modified release tablet composition comprising mirabegron
US10478399B2 (en)	2017-10-12	2019-11-19	Synthon B.V.	Modified release tablet composition comprising mirabegron
EP3694492A1 (en)	2017-10-12	2020-08-19	Synthon B.V.	Modified release tablet composition comprising mirabegron
EP3697392B1 (en)	2017-10-17	2023-11-15	Synthon B.V.	Tablets comprising tamsulosin and solifenacin

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS56110665A (en) *	1980-02-08	1981-09-01	Yamanouchi Pharmaceut Co Ltd	Sulfamoyl-substituted phenetylamine derivative and its preparation
US5391825A (en) *	1980-02-08	1995-02-21	Yamanouchi Pharmaceutical Co., Ltd.	Sulfamoyl substituted phenethylamine intermediates
US4772475A (en) *	1985-03-08	1988-09-20	Yamanouchi Pharmaceutical Co., Ltd.	Controlled-release multiple units pharmaceutical formulation
DE3681348D1 (en) *	1985-06-11	1991-10-17	Teijin Ltd	ORAL DRUG PREPARATION WITH RETARDIVE EFFECT.
GB8626098D0 (en) *	1986-10-31	1986-12-03	Euro Celtique Sa	Controlled release hydromorphone composition
IE60311B1 (en) *	1987-09-24	1994-06-29	American Home Prod	Sustained release etodolac
US5478577A (en) *	1993-11-23	1995-12-26	Euroceltique, S.A.	Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
EP0667775A1 (en) *	1992-11-04	1995-08-23	Sepracor, Inc.	Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
NZ260408A (en) *	1993-05-10	1996-05-28	Euro Celtique Sa	Controlled release preparation comprising tramadol
EP0710486A4 (en) *	1993-07-14	1997-07-09	Yamanouchi Pharma Co Ltd	Remedy for urination disorder accompanying prostatic hypertrophy
US5576014A (en) *	1994-01-31	1996-11-19	Yamanouchi Pharmaceutical Co., Ltd	Intrabuccally dissolving compressed moldings and production process thereof
US5503843A (en) *	1994-04-22	1996-04-02	Flora Inc.	Transdermal delivery of alpha adrenoceptor blocking agents
US5945125A (en) *	1995-02-28	1999-08-31	Temple University	Controlled release tablet
JPH09323926A (en) *	1996-03-15	1997-12-16	Nikken Chem Co Ltd	Sustained release tablet of sodium valproate
JP2001507359A (en) *	1997-01-03	2001-06-05	エランコーポレーションピーエルシー	Sustained release cisapride mini tablet formulation
US5843472A (en) *	1997-02-28	1998-12-01	Cygnus, Inc.	Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
JP4221068B2 (en) *	1997-12-17	2009-02-12	興和創薬株式会社	Theophylline sustained release tablet and method for producing the same
US6099859A (en) *	1998-03-20	2000-08-08	Andrx Pharmaceuticals, Inc.	Controlled release oral tablet having a unitary core
TW536402B (en) *	1998-06-26	2003-06-11	Yamanouchi Pharma Co Ltd	Pharmaceutical composition for the therapy of voiding dysfunction
JP2000080032A (en) *	1998-06-26	2000-03-21	Yamanouchi Pharmaceut Co Ltd	Remedy for excretion disorder
JP2000128774A (en) *	1998-10-26	2000-05-09	Tanabe Seiyaku Co Ltd	Production of globular, fine grain including medicine
US6419960B1 (en) *	1998-12-17	2002-07-16	Euro-Celtique S.A.	Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6248363B1 (en) *	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
HU230440B1 (en) *	1999-03-31	2016-06-28	Janssen Pharmaceutica N.V	Pregelatinized starch in a controlled release formulation
DE60035579T2 (en) *	1999-05-20	2008-04-17	Elan Corp. Plc	MULTIPARTICELY MEDICAMENT COMPOSITIONS WITH A CONTROLLED ACTIVE INGREDIENT DELIVERING SELECTIVE INHIBITORS OF SEROTONIN RECOVERY
EP1064938A1 (en) *	1999-06-28	2001-01-03	Sanofi-Synthelabo	Pharmaceutical dosage forms for controlled release producing at least a timed pulse
JP3154710B1 (en) *	1999-08-09	2001-04-09	山之内製薬株式会社	Lower urinary tract disorders
CN1192769C (en) *	1999-08-09	2005-03-16	山之内制药株式会社	Medicinal compositions for treating lower uropathy
GB9924020D0 (en) *	1999-10-11	1999-12-15	Pfizer Ltd	Pharmaceutically active compounds
IL141235A (en) *	2000-02-09	2012-04-30	Novartis Int Pharm Ltd	Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the manufacture of a medicament for the treatment of benign prostatic hyperplasia
GB0008332D0 (en) *	2000-04-04	2000-05-24	Pfizer Ltd	Treament
US6368628B1 (en) *	2000-05-26	2002-04-09	Pharma Pass Llc	Sustained release pharmaceutical composition free of food effect
US6287599B1 (en) *	2000-12-20	2001-09-11	Shire Laboratories, Inc.	Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
DE10109763A1 (en) *	2001-02-28	2002-09-05	Gruenenthal Gmbh	Pharmaceutical salts
DE20220604U1 (en) *	2001-07-27	2004-02-26	Yamanouchi Pharmaceutical Co., Ltd.	Composition containing fine long-term release particles for tablets that disintegrate quickly in the oral cavity
DE20220415U1 (en) *	2001-11-07	2003-10-09	Synthon Bv	Tamsulosin tablets

2002
- 2002-11-01 DE DE20220415U patent/DE20220415U1/en not_active Expired - Lifetime
- 2002-11-01 ES ES02775597T patent/ES2256544T3/en not_active Expired - Lifetime
- 2002-11-01 SI SI200230306T patent/SI1443917T1/en unknown
- 2002-11-01 AT AT02775597T patent/ATE321544T1/en not_active IP Right Cessation
- 2002-11-01 WO PCT/NL2002/000695 patent/WO2003039530A1/en active IP Right Grant
- 2002-11-01 EP EP02775597A patent/EP1443917B1/en not_active Expired - Lifetime
- 2002-11-01 NZ NZ532589A patent/NZ532589A/en unknown
- 2002-11-01 DK DK02775597T patent/DK1443917T3/en active
- 2002-11-01 HU HU0401978A patent/HUP0401978A3/en unknown
- 2002-11-01 NL NL1021822A patent/NL1021822C2/en not_active IP Right Cessation
- 2002-11-01 IL IL16149102A patent/IL161491A0/en unknown
- 2002-11-01 CN CNB028217357A patent/CN1298317C/en not_active Expired - Fee Related
- 2002-11-01 CA CA002465110A patent/CA2465110A1/en not_active Abandoned
- 2002-11-01 ZA ZA200403281A patent/ZA200403281B/en unknown
- 2002-11-01 RU RU2004117081/15A patent/RU2311903C2/en active
- 2002-11-01 PT PT02775597T patent/PT1443917E/en unknown
- 2002-11-01 JP JP2003541821A patent/JP2005512997A/en active Pending
- 2002-11-01 DE DE60210315T patent/DE60210315T2/en not_active Expired - Lifetime
- 2002-11-06 CA CA2464689A patent/CA2464689C/en not_active Expired - Lifetime
- 2002-11-06 ES ES02780143T patent/ES2287333T5/en not_active Expired - Lifetime
- 2002-11-06 CZ CZ200617866U patent/CZ16813U1/en not_active IP Right Cessation
- 2002-11-06 DE DE60221691.5T patent/DE60221691T3/en not_active Expired - Lifetime
- 2002-11-06 IL IL16152502A patent/IL161525A0/en unknown
- 2002-11-06 RU RU2004117080/15A patent/RU2335280C2/en active
- 2002-11-06 SI SI200230592T patent/SI1441713T2/en unknown
- 2002-11-06 EP EP02780143.0A patent/EP1441713B2/en not_active Expired - Lifetime
- 2002-11-06 CN CNA028229223A patent/CN1589139A/en active Pending
- 2002-11-06 HU HU0402004A patent/HU230830B1/en unknown
- 2002-11-06 CZ CZ200617867U patent/CZ16814U1/en not_active IP Right Cessation
- 2002-11-06 AT AT02780143T patent/ATE369128T2/en active
- 2002-11-06 WO PCT/NL2002/000710 patent/WO2003039531A1/en active IP Right Grant
- 2002-11-06 DK DK02780143.0T patent/DK1441713T4/en active
- 2002-11-06 DE DE20221486U patent/DE20221486U1/en not_active Expired - Lifetime
- 2002-11-06 JP JP2003541822A patent/JP2005511591A/en not_active Withdrawn
- 2002-11-06 EP EP05017380A patent/EP1595538A3/en not_active Withdrawn
- 2002-11-06 AU AU2002301845A patent/AU2002301845B2/en not_active Expired
- 2002-11-06 NL NL1021857A patent/NL1021857C2/en not_active IP Right Cessation
- 2002-11-06 CZ CZ200617349U patent/CZ16809U1/en not_active IP Right Cessation
- 2002-11-06 PT PT02780143T patent/PT1441713E/en unknown
- 2002-11-06 CN CN2011102907062A patent/CN102327250A/en active Pending
- 2002-11-06 NZ NZ532592A patent/NZ532592A/en not_active IP Right Cessation
- 2002-11-07 US US10/289,385 patent/US20030147950A1/en not_active Abandoned
- 2002-11-07 US US10/289,387 patent/US20030147955A1/en not_active Abandoned
2004
- 2004-04-19 IL IL161491A patent/IL161491A/en not_active IP Right Cessation
- 2004-04-20 IL IL161525A patent/IL161525A/en active IP Right Grant
- 2004-05-06 ZA ZA200403430A patent/ZA200403430B/en unknown
- 2004-06-07 NO NO20042375A patent/NO340960B1/en not_active IP Right Cessation
- 2004-06-07 NO NO20042374A patent/NO20042374L/en not_active Application Discontinuation
2005
- 2005-12-12 AT AT0084805U patent/AT9978U1/en not_active IP Right Cessation
- 2005-12-22 DK DK200500297U patent/DK200500297U3/en not_active IP Right Cessation
2010
- 2010-10-15 JP JP2010232415A patent/JP5536610B2/en not_active Expired - Lifetime

Publication	Publication Date	Title
AU2002301845A1 (en)	2003-06-12	Modified release tamsulosin tablets
HUP0402004A3 (en)	2008-08-28	Modified release tamsulosin tablets
AU2002327068A1 (en)	2003-04-14	Immediate release tablet
AU2003262059A1 (en)	2004-04-30	Sustained release preparation
AU2003241483A1 (en)	2003-11-11	Push release loop
AU2002359414A1 (en)	2003-06-10	Interposer
AU2002315779A1 (en)	2003-05-22	Soft capsules
AU2002363360A1 (en)	2003-05-19	Dual controlled release dosage form
AU2003219814A1 (en)	2003-09-09	Release agents
AUPR602501A0 (en)	2001-07-26	Sustained release pharmaceutical composition
AUPR951501A0 (en)	2002-01-24	Modified sustained release pharmaceutical system
AU2002359382A1 (en)	2003-05-26	Quick release assembly
AU2002343227A1 (en)	2003-05-19	Modified release tamsulosin tablets
AU2002301844B2 (en)	2007-05-03	Tamsulosin tablets
AU2002341442A1 (en)	2003-05-19	Tamsulosin tablets
AU2002301844A1 (en)	2003-06-12	Tamsulosin tablets
AU2003229163A1 (en)	2003-11-11	Extended release tablets comprising felodipine
AU2002334741A1 (en)	2003-04-07	Modified release dosage forms
AU2002334731A1 (en)	2003-04-07	Modified release dosage forms
AU2002347776A1 (en)	2003-04-07	Modified release dosage forms
AU2002341502A1 (en)	2003-04-22	Release device
AUPR284701A0 (en)	2001-03-01	Release mechanism
AU2002354571A1 (en)	2003-01-29	Tablet cryotechnology
AU2002302841A1 (en)	2003-03-03	Capsules
AU2002323447A1 (en)	2003-03-18	Sustained release preparations